sattva s. neelapu, md: encouraging results for car t-cells in refractory dlbcl

Published 7 years ago • 1.4K plays • Length 6:21

Download video MP4
Download video MP3

Similar videos

3:09

sattva neelapu, md, discusses advancements in the management of car t-cell therapy aes
2:25

sattva neelapu, md, shares highlights in the development of car t-cell therapies in lymphoma
$frederick locke, md: car t-cell therapy in relapsed/refractory nhl$ 7:14

frederick locke, md: car t-cell therapy in relapsed/refractory nhl
1:34

sattva neelapu, md, speculates on the future of first-line car t-cell therapy in lymphoma
3:53

what is car-t cell therapy?
34:53

engineered t cell with cars and tcrs for hematologic malignancy
18:33

car t-cell therapy: reprogramming the immune system to treat cancer | rob weinkove | tedxtauranga
1:01

sattva neelapu, md, on the possibility to enhance t-cell proliferation for a higher response rate
0:50

sattva neelapu, md, on new targets being evaluated which could make car-t therapies more effective
$stephen j. schuster, md: tisagenlecleucel promising in relapsed/refractory dlbcl$ 8:54

stephen j. schuster, md: tisagenlecleucel promising in relapsed/refractory dlbcl
1:17

sattva neelapu, md, explains what the results of zuma-1 mean to dlbcl patients
1:43

dr. neelapu on third-line car t-cell therapy in large b-cell lymphoma
1:22

zuma-19: maximizing safety of car t-cell therapy in lbcl
1:33

sattva neelapu, md, shares his approach to optimizing car t-cell therapies
1:23

sattva neelapu, md, discusses efficacy results of the zuma-1 trial
1:30

sattva neelapu, md, considers whether off-the-shelf car-t cell therapy is becoming a reality
0:59

sattva neelapu, md shares his advice for sites that are new to treating with car t-cell therapies
1:50

dr. neelapu on potential advantages of allogeneic car t-cell therapy in lymphoma
3:41

first multicenter trial of car t cells shows response in dlbcl
1:26

sattva neelapu, md, speculates on the future of car-t therapies in lymphoma
3:50

updates in the management of car-t toxicities
2:16

sattva neelapu, md, on the role of car nk cell therapy in the treatment of b-cell malignancies

Clip.africa.com - Privacy-policy